Status:
UNKNOWN
Role of Acetylcysteine in Creatinine Clearance
Lead Sponsor:
Eastern Virginia Medical School
Conditions:
Creatinine Clearance
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the exact role of Acetylcysteine (Mucomyst) in altering creatinine clearance. Prior studies have shown the protective effects of Acetylcysteine on contrast-...
Eligibility Criteria
Inclusion
- Between the ages of 18 and 79 years
- In good general health
- Able to provide informed consent
Exclusion
- Allergy to acetylcysteine or cimetidine,
- Age less than 18 years or greater than 79 years of age,
- Women of childbearing age and not able to use adequate contraception, or 4. Anyone currently on any medication that interferes with tubular secretion of creatinine such as trimethoprim-sulfamethoxazole (Bactrim).
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00396396
Start Date
October 1 2006
Last Update
November 6 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eastern Virginia Medical School/Nephrology Associates
Norfolk, Virginia, United States, 23507